Brain training and exercise from home: a new hope for early schizophrenia?

NCT ID NCT05890183

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study tests whether combining aerobic exercise with computerized cognitive training, both delivered via telehealth, can improve thinking and motivation in people who have recently experienced a first episode of schizophrenia. About 100 participants will receive cognitive training, and half will also be assigned to an exercise program, while the other half joins a healthy living group. The trial measures changes in cognitive performance, blood levels of a protein linked to brain plasticity, and engagement in the program, aiming to see if this approach is feasible and effective outside a research clinic.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Aerobic exercise and strength training combined with computerized cognitive training, delivered via telehealth
What this could lead to
If effective, this approach could offer a practical, home-based way to improve thinking and daily functioning for people early in schizophrenia, potentially reducing long-term disability.
What could go wrong
This is an early-stage trial with a modest number of participants, so results may not apply broadly. The benefits of exercise on cognition are not guaranteed, and adherence to the program may be challenging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOAFFECTIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UCLA Aftercare Research Program

    RECRUITING

    Los Angeles, California, 90095-6968, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.